Table 3:

Outcome

Variables	Group I (n = 24)	Group II (n = 26)	Group III (n = 27)	P-value
Re-exploration for bleeding, n (%)	1 (4)*	2 (8)†	10 (37)	0.002
ICU transfusion
Red blood cells, n	0 (0–0)#	2.0 (0–3.0)‡	3.0 (0.5–5.0)	<0.0001
FFP, n	—	3 (2–4)	3 (2–4)	0.58
Platelets, units	0 (0–0)	0 (0–0)	0 (0–7)	0.10
First 24-h colloids/crystalloids infusion in ICU (ml/kg)	10 (0–16)	11 (0–16)**	6 (0–13)	0.43
Thromboembolic events, n (%)	0	1 (4)	0	0.37
Pericardial effusion, n (%)	8 (33)	4 (15)	12 (44)	0.07
Pulmonary oedema, n (%)	1 (4)	1 (4)	2 (7)	0.81
ARDS, n (%)	0	0	1 (4)	0.39
Mediastinitis, n (%)	3 (12)	2 (8)	2 (7)	0.78
Other infections, n (%)	7 (29)	7 (27)	77 (27)	0.97
Duration of MV (hours)	6.0 (4.5–12.0)	14.5 (8.0–19.0)††	12.0 (7.2–20.0)‡‡	0.02
ICU stay (days)	3 (2–6)	3 (2–4)	3 (2–4)	0.82
Hospital stay (days)	12 (10–15)	15 (12–23)	12 (9–20)	0.12
Death, n (%)	0	1 (4)	3 (11)	0.19

ICU: intensive care unit; FFP: fresh frozen plasma; ARDS: acute respiratory distress syndrome; MV: mechanical ventilation.

*Group I vs group III: P = 0.004.

†Group II vs group III: P = 0.01.

^#Group I vs group II: P < 0.0007.

^‡Group I vs group III: P < 0.0001.

**Group II vs group III: P = 0.002.

^††Group I vs group II: P = 0.02.

^‡‡Group I vs group III: P = 0.01.